filmov
tv
Novartis CEO Narasimhan on Growth Prospects, Pandemic Disruption
Показать описание
Jul.21 -- Novartis AG Chief Executive Officer Vasant Narasimhan discusses second-quarter earnings, efforts to find a Covid-19 vaccine, and growth prospects. He speaks on "Bloomberg Markets: European Open" after the Swiss drugmaker trimmed its sales forecast for the year as the coronavirus pandemic hit demand for the eye drug Lucentis and other medicines.
Novartis CEO Vas Narasimhan: Expect solid growth this year top and bottom line
Novartis CEO Narasimhan on Growth Prospects, Pandemic Disruption
Novartis CEO: Expect continued growth in 2023
Novartis CEO Narasimhan on COVID, Treatments
Novartis CEO Vas Narasimhan on The David Rubenstein Show
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
Novartis' Vasant Narasimhan Exclusive On The Firm's Growth Outlook & Drug Patents | CN...
Novartis CEO: Confident about continued sales growth for rest of year
Novartis CEO discusses how AI will impact drug development
Innovative medicines business returning to growth, Novartis CEO says
Hopeful to Accelerate Growth in Second Half: Novartis CEO Vas Narasimhan
Cautiously Hopeful Of AI's Role In Drug Discovery: Novartis CEO Vas Narasimhan
Vas Narasimhan Discusses Novartis's India Strategy, Growth Outlook | Global Dialogues | CNBC-TV...
Novartis CEO Vas Narasimhan on the latest research on a breast cancer drug
Novartis CEO: Growth drivers performing well, but product exclusivity losses creating headwinds
Novartis CEO Vas Narasimhan: Strategic Approach to Weight-Loss Drug Development | N18V | CNBC TV18
A message about Managed Access from Vas Narasimhan CEO Novartis
Watch CNBC's full interview with Novartis CEO Vas Narasimhan
Novartis Financial Results Q3 2021
Novartis CEO Vas Narasimhan on Covid-19 Antibodies
Leading in Complexity: Novartis CEO Vas Narasimhan in conversation with Jennifer Garvey Berger
Novartis commitment to ESG
Novartis CEO: Nations pulling back on health care spending ‘has long-term consequences'
Novartis expects 'strong momentum' going into second half, says CEO Vasant Narasimhan
Комментарии